Thyrotoxicosis with diffuse goiter with thyrotoxic crisis or storm
ICD-10 E05.01 is a billable code used to indicate a diagnosis of thyrotoxicosis with diffuse goiter with thyrotoxic crisis or storm.
Thyrotoxicosis with diffuse goiter and thyrotoxic crisis, also known as thyroid storm, is a life-threatening condition characterized by an extreme overproduction of thyroid hormones. This condition typically arises in patients with pre-existing hyperthyroidism, often due to Graves' disease, and is exacerbated by stressors such as infection, surgery, or trauma. Clinically, patients may present with symptoms including fever, tachycardia, hypertension, agitation, and altered mental status. The diffuse goiter indicates an enlargement of the thyroid gland, which is often palpable and may be associated with a hypermetabolic state. Diagnosis is confirmed through thyroid function tests showing elevated levels of free T4 and T3, alongside suppressed TSH levels. Immediate treatment is critical and may involve antithyroid medications, beta-blockers, and supportive care to stabilize the patient. Understanding the nuances of this condition is essential for accurate coding and appropriate management.
Thorough documentation of thyroid function tests, clinical symptoms, and treatment plans.
Management of patients presenting with acute thyrotoxicosis, monitoring of thyroid hormone levels, and treatment adjustments.
Ensure that all relevant lab results and clinical observations are documented to support the diagnosis.
Detailed notes on patient presentation, vital signs, and immediate interventions performed.
Patients presenting with symptoms of thyroid storm requiring rapid assessment and stabilization.
Document the timeline of symptom onset and interventions to establish the urgency of the condition.
Used to confirm diagnosis of thyrotoxicosis in patients presenting with symptoms.
Document the rationale for testing and results to support diagnosis.
Endocrinologists should ensure comprehensive lab panels are ordered.
Key symptoms include fever, tachycardia, agitation, confusion, and gastrointestinal disturbances. Patients may also exhibit signs of hypermetabolism such as weight loss and heat intolerance.
